The Drive For Quality: Aiming For Success In Early mAb Process Development And Beyond

Unwanted variability in cell culture media can significantly impact mAb manufacturing, leading to inconsistent product titers and suboptimal critical quality attributes, especially as processes scale up. Trace elements in raw materials and inconsistencies during the media manufacturing process itself are common sources of this variability. Implementing rigorous quality control measures, such as strict sourcing protocols and robust, traceable supply chains, can mitigate these risks.

Ensuring consistent media quality and a reliable supply throughout development is vital to avoid costly delays and complexities. Discover comprehensive strategies for reducing variability and securing your supply—download the article below.